Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Mechanisms and Clinical Implications of Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

    ... not completely prevent thrombosis. Eculizumab , a monoclonal antibody to complement factor C5, effectively reduces intravascular ...

    Research Article last updated 11/21/2011 - 3:08pm.

  2. Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

    ... (SAA). We hypothesized that the humanized anti-CD52 monoclonal antibody , alemtuzumab , might be active in SAA due to its ...

    Research Article last updated 11/16/2011 - 1:57pm.

  3. Long term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

    ... intravascular hemolysis . Eculizumab , a monoclonal antibody against the complement protein C5, stops the intravascular ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab.

    ... patients with daclizumab , a humanized monoclonal antibody to the interleukin-2 receptor; we now report our long-term ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. How I treat paroxysmal nocturnal hemoglobinuria.

    ... only curative therapy for PNH. Eculizumab , a monoclonal antibody that blocks terminal complement activation, is highly effective ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Paroxysmal nocturnal hemoglobinuria from bench to bedside

    ... reagent diagnosing PNH. Eculizumab , a humanized monoclonal antibody against C5, is the first effective drug therapy for PNH. ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab.

    ... labor and fetal loss. Eculizumab , a humanized monoclonal antibody directed against the terminal complement protein C5, has ...

    Research Article last updated 10/11/2011 - 5:58pm.